Clorox is Dealing With Several Years of Challenging Circumstances | CLX Stock Analysis
Summary
Parkev analyzes the current challenges facing Clorox, noting a "double whammy" of consumers shifting to cheaper private labels and rising input costs due to inflation and geopolitical factors. Parkev observes that while Clorox did not manage the pandemic-era demand surge as effectively as companies like Home Depot or Amazon, it avoided catastrophic capacity expansion errors. Parkev highlights that Clorox's operating margins have fallen from a peak of 23% to 9%, yet the company maintains a return on capital that exceeds its weighted average cost of capital.
Parkev emphasizes that Clorox is currently trading at a historically low forward price-to-earnings ratio of 13. Parkev also points to the attractive dividend yield of over 6% as a strong incentive for passive income investors. Even after adjusting his financial models for more difficult macroeconomic conditions in 2025 and 2026, Parkev identifies significant upside potential based on fundamental valuation.
Mentioned Stocks
Reasoning: Parkev sees a 34% upside potential for Clorox, setting a fair value price target of $110 compared to the current price of $81. Parkev argues that the forward P/E of 13 is a historical low and the dividend yield of over 6% provides a great opportunity for passive income. Despite lowered expectations in his DCF model due to macro headwinds in 2025-2026, Parkev maintains a medium level of confidence in the stock's recovery.